XML 40 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Award Programs (Tables)
 3 Months Ended
Mar. 31, 2018
Stock Options and Award Programs [Abstract]  
Nonvested Restricted Stock Shares Activity [Table Text Block]
A summary of RSA activity as of March 31, 2018 and 2017, and changes during the three month periods ended March 31, 2018 and 2017 are set forth below:
 
 
 
2018
 
 
2017
 
 
 
(Unaudited)
 
NON-VESTED AWARDS
 
 
 
 
 
 
 
 
Non-vested awards outstanding, January 1,
 
 
-
 
 
 
250,000
 
Granted (+)
 
 
980,851
(1)
 
 
300,000
(2)
Vested (-)
 
 
-
 
 
 
125,000
(3)
Non-vested awards outstanding, March 31,
 
 
980,851
(4)
 
 
425,000
(4)
 
 
 
 
 
 
 
 
 
Weighted-average remaining contractual life (in years)
 
 
1.3
 
 
 
2.8
 
 
 
 
 
 
 
 
 
 
Unamortized RSA compensation expense
 
$
474,116
 
 
$
243,188
 
 
 
 
 
 
 
 
 
 
Aggregate intrinsic value of RSAs non-vested, March 31
 
$
568,894
 
 
$
191,250
 
 
 
 
 
 
 
 
 
 
Aggregate intrinsic value of RSAs vested, March 31
 
$
-
 
 
$
108,750
 
 
(1) During the three month period ended March 31, 2018, the Company granted 980,851 RSAs, of which i) 300,000 of RSAs were awarded as part of additional compensation plan to align key employees with the Company’s long term financial goals, and ii) 680,851 were awarded to members of the Company’s board of directors.
 
(2) During the three month period ended March 31, 2017, the Company granted 300,000 RSAs to its former Chief Executive Officer that had a grant date fair value of approximately $246,000. The vesting of these RSAs were tied to attainment of certain financial goals as outlined by the Company’s Compensation Committee of the Board of Directors. On June 30, 2017, in connection with resignation of our former Chief Executive Officer the Board of Directors accelerated vesting of 150,000 RSAs and cancelled the remaining unvested RSAs.
  
(3) During the three month period ended March 31, 2017, 125,000 RSAs vested upon expiration of the employment agreement between Steve L. Komar and the Company. On January 3, 2017, the Company issued 84,188 shares of the Company’s common stock. Mr. Komar received less than 125,000 shares vested because he elected to have 40,812 of such shares withheld in satisfaction of the corresponding tax liability of approximately $46,000. The Company's payment of this tax liability was recorded as a cash flow from financing activity on the Condensed Consolidated Statements of Cash Flows.
 
(4) There were no RSAs that were cancelled or expired during the three month periods ended March 31, 2018 and 2017, respectively.
Schedule of Nonvested Share Activity [Table Text Block]
A summary of stock option activity as of March 31, 2018 and 2017, and changes during the three month periods ended March 31, 2018 and 2017 are set forth below:
 
 
 
2018
 
2017
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
Average
 
 
 
 
 
Average
 
 
 
 
 
 
 
Grant Date
 
 
 
 
 
Grant Date
 
 
 
Shares
 
 
Fair Value
 
Shares
 
 
Fair Value
 
 
 
(Unaudited)
 
NON-VESTED AWARDS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-vested balances, January 1,
 
 
2,685,004
 
 
$
0.35
 
 
920,000
 
 
$
0.59
 
Granted (+)
 
 
-
(1)
 
$
0.00
 
 
600,000
(2)
 
$
0.48
 
Cancelled (-)
 
 
-
(1)
 
$
0.00
 
 
60,000
(3)
 
$
0.68
 
Non-vested balances, March 31,
 
 
2,685,004
 
 
$
0.35
 
 
1,460,000
 
 
$
0.54
 
 
(1) During the three month period ended March 31, 2018, there were no grants, cancellations, or vesting of non-qualified stock options.
 
(2) During the three month period ended March 31, 2017, the Company granted 600,000 NQSOs to its former Chief Executive Officer and valued the award using a Black-Scholes model with the following valuation inputs: 3-year vesting period, 7-year option term, a risk free rate of 2.1%, volatility of 68.2%, no assumed dividend yield, and a forfeiture rate estimate of 4.6%. On June 30, 2017, in connection with resignation of our former Chief Executive Officer the Board of Directors cancelled all unvested NQSOs.
 
(3) During the three month period ended March 31, 2017, there were 70,000 stock options, 60,000 of which were unvested and were cancelled due to termination of employment and the remainder expired unexercised at the end of the option term.
Schedule Of Share-Based Compensation, Stock Options, Activity [Table Text Block]
 
 
2018
 
2017
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
Average
 
 
 
 
 
Average
 
 
 
Shares
 
 
Exercise Price
 
Shares
 
 
Exercise Price
 
 
 
(Unaudited)
 
OUTSTANDING AND EXERCISABLE AWARDS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Awards outstanding, January 1,
 
 
4,173,334
 
 
$
0.60
 
 
2,090,668
 
 
$
0.86
 
Granted (+)
 
 
-
(1)
 
$
0.00
 
 
600,000
(2)
 
$
0.82
 
Cancelled (-)
 
 
-
(1)
 
$
0.00
 
 
70,000
(3)
 
$
0.79
 
Exercised (-)
 
 
50,000
(4)
 
$
0.44
 
 
30,000
 
 
$
0.57
 
Awards outstanding, March 31,
 
 
4,123,334
 
 
$
0.00
 
 
2,590,668
 
 
$
0.85
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Awards vested and expected to vest, March 31,
 
 
3,527,089
 
 
$
0.60
 
 
2,392,908
 
 
$
0.85
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Awards outstanding and exercisable, March 31,
 
 
1,438,330
 
 
$
0.62
 
 
1,130,668
 
 
$
0.82
 
 
(1) During the three month period ended March 31, 2018, there were no grants, cancellations, or vesting of non-qualified stock options.
 
(2) During the three month period ended March 31, 2017, the Company granted 600,000 NQSOs to its former Chief Executive Officer and valued the award using a Black-Scholes model with the following valuation inputs: 3-year vesting period, 7-year option term, a risk free rate of 2.1%, volatility of 68.2%, no assumed dividend yield, and a forfeiture rate estimate of 4.6%. On June 30, 2017, in connection with resignation of our former Chief Executive Officer the Board of Directors cancelled all unvested NQSOs.
 
(3) During the three month period ended March 31, 2017, there were 70,000 stock options, 60,000 of which were unvested and were cancelled due to termination of employment and the remainder expired unexercised at the end of the option term.
 
(4) The total intrinsic value of stock options exercised during the three month ended March 31, 2018 was approximately $5,500.
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
 
 
2018
 
2017
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
Average
 
 
 
 
 
Average
 
 
 
Shares
 
 
Exercise Price
 
Shares
 
 
Exercise Price
 
 
 
(Unaudited)
 
OUTSTANDING AND EXERCISABLE AWARDS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Awards outstanding, January 1,
 
 
4,173,334
 
 
$
0.60
 
 
2,090,668
 
 
$
0.86
 
Granted (+)
 
 
-
(1)
 
$
0.00
 
 
600,000
(2)
 
$
0.82
 
Cancelled (-)
 
 
-
(1)
 
$
0.00
 
 
70,000
(3)
 
$
0.79
 
Exercised (-)
 
 
50,000
(4)
 
$
0.44
 
 
30,000
 
 
$
0.57
 
Awards outstanding, March 31,
 
 
4,123,334
 
 
$
0.00
 
 
2,590,668
 
 
$
0.85
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Awards vested and expected to vest, March 31,
 
 
3,527,089
 
 
$
0.60
 
 
2,392,908
 
 
$
0.85
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Awards outstanding and exercisable, March 31,
 
 
1,438,330
 
 
$
0.62
 
 
1,130,668
 
 
$
0.82
 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
Share-based compensation (including restricted stock awards) represents both stock options based expense and stock grant expense. The following table sets forth the composition of stock compensation expense included in general and administrative expense for the periods then ended:
 
 
 
THREE MONTHS ENDED
 
 
 
MARCH 31,
 
 
 
2018
 
2017
 
 
 
 
 
 
 
 
 
 
 
(Unaudited)
 
Restricted stock compensation expense
 
$
49,884
 
$
22,054
 
Non-qualified stock option compensation expense
 
 
74,520
 
 
62,963
 
 
 
 
 
 
 
 
 
Total share-based compensation before taxes
 
$
124,404
 
$
85,017